MedPath

Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule

Not Applicable
Conditions
Celiac Disease
Healthy
Interventions
Device: OFDI Capsule
Registration Number
NCT02202681
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The study is being done to assess the tolerability and feasibility of a tethered OFDI capsule to image the duodenum.

A total of 24 subjects will be asked to swallow the tethered capsule, while they are awake and unsedated and ask for their feedback. Images will be taken using the OFDI system while the capsule travels from the esophagus into the stomach and into the duodenum.

Detailed Description

Subjects including healthy volunteers as well as patients with Celiac disease will be recruited and asked to swallow the OFDI capsule while being awake and unsedated. The capsule is attached to a tether which allows the operator to control as well as navigate the capsule as it progresses down the esophagus, through the stomach and into the duodenum using natural propulsive force called peristalsis.

As the capsule progresses, multiple 2-dimensional cross sectional images of the duodenum are acquired. Images are analyzed at a later stage.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
108
Inclusion Criteria
  • Subject must be over 18 years for healthy volunteers
  • Subjects must be over 16 years for patients with Celiac disease
  • Subject must be able to give informed consent
Exclusion Criteria
  • Subjects with an inability to swallow pills or capsules.
  • Subjects with esophageal or intestinal fistulas.
  • Subjects with known esophageal or intestinal strictures resulting in a luminal diameter smaller than the diameter of the capsule.
  • Subjects with a history of intestinal Crohn's disease.
  • Women who are pregnant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OFDI Capsule ImagingOFDI CapsuleSubject will swallow the OFDI Capsule and imaging will be performed using the OFDI system.
Primary Outcome Measures
NameTimeMethod
Tolerability of OFDI Imaging in subjects swallowing the OFDI capsuleImages will be acquired during the OFDI imaging session which should on average take anywhere from 30 minutes to 2 hours.

After participating in the study, the subject will be asked for feedback about tolerability of the procedure using a questionnaire.

Feasibility of OFDI Imaging in subjects swallowing the OFDI capsuleImages will be acquired during the OFDI imaging session which should on average take anywhere from 30 minutes to 2 hours

An investigator will assess the quality of the recorded images and movies obtained with each exam after the imaging is completed.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath